Hamlet PharmaHamlet PharmaHamlet Pharma
  • Home
  • About Hamlet Pharma
    • Finance and Strategy
    • Patents
    • Who Gets Cancer
  • Clinical Trials
  • Science
  • Investors
    • Financial Reports
    • Annual General Meeting 2020
  • News
  • Contact
Hamlet Pharma
Category

News

News

The therapeutic effect of Alpha1H, Hamlet Pharma’s drug candidate, increases substantially with the treatment dose

News

New date for the Annual General Meeting

News

Announcing the Film Premiere “Mother’s Milk”

News

Prof. Catharina Svanborg appointed Chief Medical Officer of HAMLET Pharma, overseeing clinical trials

News

New patent to treat and prevent gastrointestinal cancer is in order for grant

News

Press Release: Ethical approval for the bladder cancer clinical study

News

Press Release: Large-scale production of the Alpha1H peptide is ready for clinical trials

News

HAMLET Pharma’s strategic decision

News

HAMLET Pharma attracts International Media Attention

Previous 1 2 3

HAMLET Pharma AB is a pharmaceutical company with strong links to research, working with natural and biological substances.

Swedish

© 2021 Hamlet Pharma.

  • Home
  • About Hamlet Pharma
    • Finance and Strategy
    • Patents
    • Who Gets Cancer
  • Clinical Trials
  • Science
  • Investors
    • Financial Reports
    • Annual General Meeting 2020
  • News
  • Contact

Hamlet Pharma AB

BMC D10
Klinikgatan 32
SE-222 42 Lund, Sweden
+46 40 12 25 00
info@hamletpharma.com

Swedish